The cost-effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 9, 2009, Pages 1196-1203

  Eddama, O ^a   Petrou, S ^a   Schroeder, L ^a   Bollapragada, S S ^b   MacKenzie, F ^c   Norrie, J ^d   Reid, M ^b   Norman, J E ^e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Princess Royal Maternity ^*  (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Economic evaluation; Induction of labour; Isosorbide mononitrate; Obstetrics

Indexed keywords

ISOSORBIDE MONONITRATE; OXYTOCIN; PLACEBO;

ARTICLE; CESAREAN SECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DELIVERY; DRUG SELF ADMINISTRATION; ECONOMIC EVALUATION; EPIDURAL ANESTHESIA; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HOME CARE; HOSPITAL ADMISSION; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; NULLIPARA; PREGNANCY; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX RIPENING;

AMBULATORY CARE; CERVICAL RIPENING; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; ISOSORBIDE DINITRATE; LABOR, INDUCED; NITRIC OXIDE DONORS; PREGNANCY; PRENATAL CARE;

EID: 68249160695     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2009.02236.x     Document Type: Article

References (24)

1. Caughey AB, Stotland NE, Washington AE, Escobar GJ. Maternal and obstetric complications of pregnancy are associated with increasing gestational age at term. AJOJ 2007 196 : 155.e1 6.
2. Chwalisz K, Garfield RE. Nitric oxide as the final metabolic mediator of cervical ripening. Hum Reprod 1998 13 : 245 8.
3. Ledingham MA, Thomson AJ, Greer IA, Norman JE. Nitric oxide in parturition. BJOG 2000 7 : 581 93.
4. Rayburn W, Tassone S, Pearman C. Is cervidil appropriate for outpatient cervical ripening. Obstet Gynecol 2000 95 : S63.
5. Voss DH, Cumminsky KC, Cook VD, Nethers MS, Spinnato JA, Gall SA. Effect of three concentrations of intracervical prostaglandin E2 gel for cervical ripening. J Matern Fetal Med 1996 5 : 186 93.
6. Bullarbo M, Eriksson Orrskog M, Andersch B, Bjorn A, Granstrom L, Norstrom A, et al. Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. AJOG 2007 196 : 50.e1 5.
7. Bollapragada SS, MacKenzie F, Norrie J, Eddama O, Petrou S, Reid M, et al. Randomised placebo controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour -clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP Study. BJOG 2009 DOI
8. Drummond MF, O'Brien B, Stoddart GL, Torrance G. Methods for the Economic Evaluation of Health Care Programmes. Oxford : Oxford University Press, 1997.
9. Mugford M, Hutton G, Fox-Rushby J. Methods for economic evaluation alongside a multicentre trial in developing countries: a case study form the WHO Antenatal Care Randomised Controlled Trial. Paediatr Perinat Epidemiol 1998 12 : 75 97.
10. Department of Health. National Schedule for Reference Costs. London : DoH, 2006.
11. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000 19 : 3219 36.
12. Black WC. The cost-effectiveness plane: A graphical representation of cost-effectiveness. Med Decis Making 1990 10 : 212 5.
13. Stinnett AA, Mullahy J. Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998 18 (2 Suppl S68 80.
14. Kurup A, Chua S, Arulkumaran S, Tham KF, Tay D, Ratnam SS. Induction of labour in nulliparas with poor cervical score: oxytocin or prostaglandin vaginal pessaries? Aust N Z J Obstet Gynaecol 1991 31 : 223 6.
15. Raftery J. NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ 2001 323 : 1300 3.
16. National Institute for Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal. London : NICE, 2004.
17. Longworth L, Ratcliffe J, Boulton M. Investigating women's preferences for intrapartum care: home versus hospital births. Health Soc Care Community 2001 9 : 404 13.
18. Hundley V, Ryan M, Graham W. Assessing women's preferences for intrapartum care. Birth 2001 28 : 254 63.
19. Bodner-Adler B, Bodner K, Pateisky N, Kimberger O, Chalubinski K, Mayerhofer K, et al. Influence of labour induction on obstetric outcomes in patients with prolonged pregnancy: a comparison between elective labour induction and spontaneous onset of labour beyond term. Wien Klin Wochenschr 2005 117 : 287 92.
20. Hoffman MK, Vahratian A, Sciscione AC, Troendle JF, Zhang J. Comparison of labor progression between induced and noninduced multiparous women. Obstet Gynecol 2006 107 : 1029 34.
21. Allen VM, O'Connell CM, Baskett TF. Cumulative economic implications of initial method of delivery. Obstet Gynecol 2006 108 : 549 55.
22. Tan LK, Tay SK. Two dosing regimens for preinduction cervical priming with intravaginal dinoprostone pessary: a randomised clinical trial. Br J Obstet Gynaecol 1999 106 : 907 12.
23. Karnon J. Planning the efficient allocation of research funds: an adapted application of a non-parametric Bayesian value of information analysis. Health Policy 2002 61 : 329 47.
24. Claxton K, Ginnelly L, Sculpher M, Philips Z, Palmer S. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. Health Technol Assess 2004 8 : 1 103.